Work

Phase I dose escalation study of bortezomib in combination with lenalidomide in patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).

Year: 2012

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2012.30.15_suppl.6621

Authors: Philip C. Amrein, Eyal C. Attar, Amir Tahmasb Fathi, Steven L McAfee, Martha Wadleigh, Daniel J. DeAngelo, David P. Steensma, Julia Foster, Richard M. Stone, Donna S. Neuberg, Karen K. Ballen

Institutions: Harvard University, Massachusetts General Hospital, Dana-Farber Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2597689323

Cites:

Cited by:

Related to: 10